Skip to main content
. 2012 Mar 8;103(5):921–925. doi: 10.1111/j.1349-7006.2012.02232.x

Figure 2.

Figure 2

Serum levels of conventional des‐gamma‐carboxy prothrombin (DCP), NX‐DCP, and the NX‐DCP ratio in patients with and without hepatocellular carcinoma (HCC) taking warfarin. (a) Serum levels of conventional DCP. No differences were found between two groups (P = 0.7952). (b) Serum levels of NX‐DCP were significantly higher in patients without HCC compared to those with HCC (P = 0.0291). (c) The NX‐DCP ratio was significantly higher in patients with HCC than in those without HCC, consequently (P < 0.0001).